Calcium, FSH, and the changing bones of menopause: A longitudinal look at the silent transformation
Bone · 2026
DOI: 10.1016/j.bone.2026.117805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2026. Verfasst von Jessica L Puranda und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada. Hauptthemen laut MEDLINE: Follicle Stimulating Hormone, Calcium, Menopause, Bone and Bones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research.
Abstract (Originalsprache)
INTRODUCTION: Osteoporosis poses a health risk to post-menopausal females. The menopause transition is associated with hormone fluctuations (e.g., follicle-stimulating hormone (FSH), estrogen), and other biochemical and physiological changes that contribute a decline in bone mineral density (BMD). This will investigate the relationship between biochemical and physiological markers of BMD across the menopause transition. METHODS: Fifty-six middle-aged females who completed their menopause transition were included in this longitudinal sub-analysis. Participants were recruited from the Ottawa/Gatineau region. Menopause status was classified using menstrual history and FSH plasma levels. BMD and body composition were assessed using dual-energy x-ray absorptiometry (DXA). Additional measures included BMI, cardiorespiratory fitness (VO2max), diet calcium and Vitamin D, and biochemical markers (i.e., FSH, cortisol, calcium). Statistical analysis included repeated measures analysis of variance, linear mixed modeling, and group-based trajectory modeling to identify distinct FSH trajectory groups and their associations with BMD changes over time. RESULTS: Serum calcium was negatively associated with BMD at the lumbar spine [β: -0.0799, 95% confidence interval (CI): -0.139; -0.020, p = 0.009]. Further, the high FSH trajectory group experienced a greater decrease in BMD across the 5-year period, at the femur neck [β: 0.067, CI: 0.050; 0.084 vs. β: 0.035, CI: 0.021; 0.048; p = 0.003] and total body [β: 0.045, CI: 0.035; 0.055 vs. β: 0.028, CI: 0.020; 0.036; p = 0.007] than the low FSH trajectory group. CONCLUSION: Associations between serum calcium and lumbar spine BMD, and a greater BMD decline in individuals with high FSH levels were revealed. This information suggests that serum calcium and FSH should be monitored throughout the menopause transition to protect BMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada.
- Laboratory of Experimental and Applied Physiology to Physical Activity, Midwest State University of Paraná, Guarapuava, PR, Brazil.
- School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada. Electronic address: kristi.adamo@uottawa.ca.
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
Puranda, J. L., Weber, V. M. R., Doucet, É., & Adamo, K. B. (2026). Calcium, FSH, and the changing bones of menopause: A longitudinal look at the silent transformation. Bone. https://doi.org/10.1016/j.bone.2026.117805
Vancouver
Puranda JL, Weber VMR, Doucet É, Adamo KB. Calcium, FSH, and the changing bones of menopause: A longitudinal look at the silent transformation. Bone. 2026. doi:10.1016/j.bone.2026.117805
BibTeX
@article{Puranda2026,
author = {Puranda, Jessica L and Weber, Vinicius M R and Doucet, Éric and Adamo, Kristi B},
title = {Calcium, FSH, and the changing bones of menopause: A longitudinal look at the silent transformation},
journal = {Bone},
year = {2026},
doi = {10.1016/j.bone.2026.117805}
}
EUVIMED